<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-07-19" modified="2017-05-10" version="165">
<accession>Q14680</accession>
<accession>A6P3A7</accession>
<accession>A6P3A8</accession>
<accession>B1AMQ6</accession>
<accession>B7Z1E6</accession>
<accession>B7Z5M5</accession>
<accession>B7Z6Q7</accession>
<accession>B7Z6R8</accession>
<accession>B7Z6Y0</accession>
<accession>B7Z7Q1</accession>
<accession>D3DRP8</accession>
<accession>F5H0Y0</accession>
<accession>F5H2R4</accession>
<accession>F5H689</accession>
<accession>Q7L3C3</accession>
<name>MELK_HUMAN</name>
<protein>
<recommendedName>
<fullName>Maternal embryonic leucine zipper kinase</fullName>
<shortName>hMELK</shortName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Protein kinase Eg3</fullName>
<shortName>pEg3 kinase</shortName>
</alternativeName>
<alternativeName>
<fullName>Protein kinase PK38</fullName>
<shortName>hPK38</shortName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine-protein kinase MELK</fullName>
<ecNumber>2.7.10.2</ecNumber>
</alternativeName>
</protein>
<gene>
<name type="primary">MELK</name>
<name type="synonym">KIAA0175</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2004-07" db="EMBL/GenBank/DDBJ databases">
<title>Identification of MELK whose expression was highly up-regulated in breast cancers.</title>
<authorList>
<person name="Katagiri T."/>
<person name="Lin M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5 AND 6)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="DNA Res." volume="3" first="17" last="24">
<title>Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1.</title>
<authorList>
<person name="Nagase T."/>
<person name="Seki N."/>
<person name="Ishikawa K."/>
<person name="Tanaka A."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="8724849"/>
<dbReference type="DOI" id="10.1093/dnares/3.1.17"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3; 4; 5; 7 AND 8)</scope>
<source>
<tissue>Spleen</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Colon</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="Biochem. J." volume="361" first="597" last="604">
<title>Phosphorylation of a novel zinc-finger-like protein, ZPR9, by murine protein serine/threonine kinase 38 (MPK38).</title>
<authorList>
<person name="Seong H.-A."/>
<person name="Gil M."/>
<person name="Kim K.-T."/>
<person name="Kim S.-J."/>
<person name="Ha H."/>
</authorList>
<dbReference type="PubMed" id="11802789"/>
<dbReference type="DOI" id="10.1042/0264-6021:3610597"/>
</citation>
<scope>INTERACTION WITH ZNF622</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF ZNF622</scope>
<source>
<tissue>Keratinocyte</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="7630" last="7641">
<title>Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation.</title>
<authorList>
<person name="Davezac N."/>
<person name="Baldin V."/>
<person name="Blot J."/>
<person name="Ducommun B."/>
<person name="Tassan J.P."/>
</authorList>
<dbReference type="PubMed" id="12400006"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205870"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CDC25B</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="8642" last="8647">
<title>Inhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1.</title>
<authorList>
<person name="Vulsteke V."/>
<person name="Beullens M."/>
<person name="Boudrez A."/>
<person name="Keppens S."/>
<person name="Van Eynde A."/>
<person name="Rider M.H."/>
<person name="Stalmans W."/>
<person name="Bollen M."/>
</authorList>
<dbReference type="PubMed" id="14699119"/>
<dbReference type="DOI" id="10.1074/jbc.M311466200"/>
</citation>
<scope>INTERACTION WITH PPP1R8</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF ASP-150; THR-345; THR-387; THR-409; THR-415; THR-428; THR-446; THR-460; THR-466; THR-478 AND THR-518</scope>
<scope>PHOSPHORYLATION AT THR-478</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="833" last="843">
<title>LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.</title>
<authorList>
<person name="Lizcano J.M."/>
<person name="Goeransson O."/>
<person name="Toth R."/>
<person name="Deak M."/>
<person name="Morrice N.A."/>
<person name="Boudeau J."/>
<person name="Hawley S.A."/>
<person name="Udd L."/>
<person name="Maekelae T.P."/>
<person name="Hardie D.G."/>
<person name="Alessi D.R."/>
</authorList>
<dbReference type="PubMed" id="14976552"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600110"/>
</citation>
<scope>PHOSPHORYLATION AT THR-167</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF THR-167</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="9751" last="9761">
<title>Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers.</title>
<authorList>
<person name="Gray D."/>
<person name="Jubb A.M."/>
<person name="Hogue D."/>
<person name="Dowd P."/>
<person name="Kljavin N."/>
<person name="Yi S."/>
<person name="Bai W."/>
<person name="Frantz G."/>
<person name="Zhang Z."/>
<person name="Koeppen H."/>
<person name="de Sauvage F.J."/>
<person name="Davis D.P."/>
</authorList>
<dbReference type="PubMed" id="16266996"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-04-4531"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Cell Cycle" volume="4" first="806" last="811">
<title>CDC25B phosphorylated by pEg3 localizes to the centrosome and the spindle poles at mitosis.</title>
<authorList>
<person name="Mirey G."/>
<person name="Chartrain I."/>
<person name="Froment C."/>
<person name="Quaranta M."/>
<person name="Bouche J.P."/>
<person name="Monsarrat B."/>
<person name="Tassan J.P."/>
<person name="Ducommun B."/>
</authorList>
<dbReference type="PubMed" id="15908796"/>
<dbReference type="DOI" id="10.4161/cc.4.6.1716"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CDC25B</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-505</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Cell Cycle" volume="5" first="883" last="889">
<title>M-phase MELK activity is regulated by MPF and MAPK.</title>
<authorList>
<person name="Badouel C."/>
<person name="Korner R."/>
<person name="Frank-Vaillant M."/>
<person name="Couturier A."/>
<person name="Nigg E.A."/>
<person name="Tassan J.P."/>
</authorList>
<dbReference type="PubMed" id="16628004"/>
<dbReference type="DOI" id="10.4161/cc.5.8.2683"/>
</citation>
<scope>PHOSPHORYLATION AT THR-167; SER-343; SER-356; TYR-367; THR-398; THR-409; SER-431; THR-494; SER-505 AND SER-529</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="40003" last="40011">
<title>Substrate specificity and activity regulation of protein kinase MELK.</title>
<authorList>
<person name="Beullens M."/>
<person name="Vancauwenbergh S."/>
<person name="Morrice N."/>
<person name="Derua R."/>
<person name="Ceulemans H."/>
<person name="Waelkens E."/>
<person name="Bollen M."/>
</authorList>
<dbReference type="PubMed" id="16216881"/>
<dbReference type="DOI" id="10.1074/jbc.M507274200"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>CALCIUM-BINDING</scope>
<scope>PHOSPHORYLATION AT THR-56; TYR-163; THR-167; SER-171; SER-253; SER-336; SER-343; SER-356; SER-391; THR-398; SER-407; SER-431; THR-494; SER-505; SER-529 AND THR-539</scope>
<scope>MUTAGENESIS OF CYS-29; CYS-70; CYS-89; ASP-150; CYS-154; TYR-163; CYS-168; CYS-169; SER-171; CYS-204; 283-ASP--ASP-285; CYS-286 AND CYS-339</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Biol. Cell" volume="98" first="253" last="263">
<title>Cell-cycle-dependent cortical localization of pEg3 protein kinase in Xenopus and human cells.</title>
<authorList>
<person name="Chartrain I."/>
<person name="Couturier A."/>
<person name="Tassan J.P."/>
</authorList>
<dbReference type="PubMed" id="16159311"/>
<dbReference type="DOI" id="10.1042/BC20050041"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Breast Cancer Res." volume="9" first="R17" last="R17">
<title>Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.</title>
<authorList>
<person name="Lin M.L."/>
<person name="Park J.H."/>
<person name="Nishidate T."/>
<person name="Nakamura Y."/>
<person name="Katagiri T."/>
</authorList>
<dbReference type="PubMed" id="17280616"/>
<dbReference type="DOI" id="10.1186/bcr1650"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF BCL2L14</scope>
<scope>MUTAGENESIS OF ASP-150</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Int. J. Cancer" volume="122" first="807" last="815">
<title>Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas.</title>
<authorList>
<person name="Marie S.K."/>
<person name="Okamoto O.K."/>
<person name="Uno M."/>
<person name="Hasegawa A.P."/>
<person name="Oba-Shinjo S.M."/>
<person name="Cohen T."/>
<person name="Camargo A.A."/>
<person name="Kosoy A."/>
<person name="Carlotti C.G. Jr."/>
<person name="Toledo S."/>
<person name="Moreira-Filho C.A."/>
<person name="Zago M.A."/>
<person name="Simpson A.J."/>
<person name="Caballero O.L."/>
</authorList>
<dbReference type="PubMed" id="17960622"/>
<dbReference type="DOI" id="10.1002/ijc.23189"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="J. Neurosci. Res." volume="86" first="48" last="60">
<title>Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells.</title>
<authorList>
<person name="Nakano I."/>
<person name="Masterman-Smith M."/>
<person name="Saigusa K."/>
<person name="Paucar A.A."/>
<person name="Horvath S."/>
<person name="Shoemaker L."/>
<person name="Watanabe M."/>
<person name="Negro A."/>
<person name="Bajpai R."/>
<person name="Howes A."/>
<person name="Lelievre V."/>
<person name="Waschek J.A."/>
<person name="Lazareff J.A."/>
<person name="Freije W.A."/>
<person name="Liau L.M."/>
<person name="Gilbertson R.J."/>
<person name="Cloughesy T.F."/>
<person name="Geschwind D.H."/>
<person name="Nelson S.F."/>
<person name="Mischel P.S."/>
<person name="Terskikh A.V."/>
<person name="Kornblum H.I."/>
</authorList>
<dbReference type="PubMed" id="17722061"/>
<dbReference type="DOI" id="10.1002/jnr.21471"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; SER-498; SER-505; THR-518 AND SER-529</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431 AND SER-505</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Breast Cancer Res." volume="11" first="R60" last="R60">
<title>Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer.</title>
<authorList>
<person name="Pickard M.R."/>
<person name="Green A.R."/>
<person name="Ellis I.O."/>
<person name="Caldas C."/>
<person name="Hedge V.L."/>
<person name="Mourtada-Maarabouni M."/>
<person name="Williams G.T."/>
</authorList>
<dbReference type="PubMed" id="19671159"/>
<dbReference type="DOI" id="10.1186/bcr2350"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; SER-498; SER-505 AND SER-529</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="Cancer Res." volume="70" first="8863" last="8873">
<title>Maternal embryonic leucine zipper kinase is upregulated and required in mammary tumor-initiating cells in vivo.</title>
<authorList>
<person name="Hebbard L.W."/>
<person name="Maurer J."/>
<person name="Miller A."/>
<person name="Lesperance J."/>
<person name="Hassell J."/>
<person name="Oshima R.G."/>
<person name="Terskikh A.V."/>
</authorList>
<dbReference type="PubMed" id="20861186"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-1295"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Cell" volume="143" first="966" last="977">
<title>Kinase associated-1 domains drive MARK/PAR1 kinases to membrane targets by binding acidic phospholipids.</title>
<authorList>
<person name="Moravcevic K."/>
<person name="Mendrola J.M."/>
<person name="Schmitz K.R."/>
<person name="Wang Y.H."/>
<person name="Slochower D."/>
<person name="Janmey P.A."/>
<person name="Lemmon M.A."/>
</authorList>
<dbReference type="PubMed" id="21145462"/>
<dbReference type="DOI" id="10.1016/j.cell.2010.11.028"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Exp. Cell Res." volume="316" first="2166" last="2173">
<title>Maternal embryonic leucine zipper kinase is stabilized in mitosis by phosphorylation and is partially degraded upon mitotic exit.</title>
<authorList>
<person name="Badouel C."/>
<person name="Chartrain I."/>
<person name="Blot J."/>
<person name="Tassan J.P."/>
</authorList>
<dbReference type="PubMed" id="20420823"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2010.04.019"/>
</citation>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="Biochem. Biophys. Res. Commun." volume="412" first="207" last="213">
<title>Resistance of colorectal cancer cells to radiation and 5-FU is associated with MELK expression.</title>
<authorList>
<person name="Choi S."/>
<person name="Ku J.L."/>
</authorList>
<dbReference type="PubMed" id="21806965"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2011.07.060"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="Neuro-oncol." volume="13" first="622" last="634">
<title>Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway.</title>
<authorList>
<person name="Nakano I."/>
<person name="Joshi K."/>
<person name="Visnyei K."/>
<person name="Hu B."/>
<person name="Watanabe M."/>
<person name="Lam D."/>
<person name="Wexler E."/>
<person name="Saigusa K."/>
<person name="Nakamura Y."/>
<person name="Laks D.R."/>
<person name="Mischel P.S."/>
<person name="Viapiano M."/>
<person name="Kornblum H.I."/>
</authorList>
<dbReference type="PubMed" id="21558073"/>
<dbReference type="DOI" id="10.1093/neuonc/nor023"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; SER-498; SER-505 AND SER-529</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] MET-56; ARG-219; LYS-333; ILE-348 AND MET-460</scope>
</reference>
<comment type="function">
<text evidence="17 18 19 21 23 25">Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation. Has a broad substrate specificity; phosphorylates BCL2L14, CDC25B, MAP3K5/ASK1 and ZNF622. Acts as an activator of apoptosis by phosphorylating and activating MAP3K5/ASK1. Acts as a regulator of cell cycle, notably by mediating phosphorylation of CDC25B, promoting localization of CDC25B to the centrosome and the spindle poles during mitosis. Plays a key role in cell proliferation and carcinogenesis. Required for proliferation of embryonic and postnatal multipotent neural progenitors. Phosphorylates and inhibits BCL2L14, possibly leading to affect mammary carcinogenesis by mediating inhibition of the pro-apoptotic function of BCL2L14. Also involved in the inhibition of spliceosome assembly during mitosis by phosphorylating ZNF622, thereby contributing to its redirection to the nucleus. May also play a role in primitive hematopoiesis.</text>
</comment>
<comment type="catalytic activity">
<text evidence="16 23">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="catalytic activity">
<text evidence="23">ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="23">Activated by autophosphorylation of the T-loop at Thr-167 and Ser-171: in contrast to other members of the SNF1 subfamily, phosphorylation at Thr-167 is not mediated by STK11/LKB1 but via autophosphorylation instead. Inhibited by calcium-binding. Kinase activity is also regulated by reducing agents: dithiothreitol (DTT) or reduced glutathione are required for kinase activity in vitro; such dependence is however not due to the presence of disulfide bonds.</text>
</comment>
<comment type="subunit">
<text evidence="17 19">Monomer. Interacts with ZNF622 and PPP1R8.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1046702"/>
<interactant intactId="EBI-1385773">
<id>Q9BZR8</id>
<label>BCL2L14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="22 28">Cell membrane</location>
<topology evidence="22 28">Peripheral membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q14680-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q14680-2</id>
<name>2</name>
<sequence type="described" ref="VSP_044715"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>Q14680-3</id>
<name>3</name>
<sequence type="described" ref="VSP_045208"/>
</isoform>
<isoform>
<id>Q14680-4</id>
<name>4</name>
<sequence type="described" ref="VSP_045209"/>
</isoform>
<isoform>
<id>Q14680-5</id>
<name>5</name>
<sequence type="described" ref="VSP_045430"/>
</isoform>
<isoform>
<id>Q14680-6</id>
<name>6</name>
<sequence type="described" ref="VSP_045431"/>
</isoform>
<isoform>
<id>Q14680-7</id>
<name>7</name>
<sequence type="described" ref="VSP_046760"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>Q14680-8</id>
<name>8</name>
<sequence type="described" ref="VSP_046759"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="31">Expressed in placenta, kidney, thymus, testis, ovary and intestine.</text>
</comment>
<comment type="developmental stage">
<text evidence="27">Increases during G2/M phase compared to interphase. Protein level decreases when cells exit mitosis, probably due to degradation.</text>
</comment>
<comment type="induction">
<text evidence="29 30">Up-regulated in many cancers cells. Up-regulated upon treatment with radiation or 5-fluorouracil (5-FU) in colorectal cancer cells, suggesting that it might be associated with increased resistance of colorectal cells against radiation and 5-FU. Down-regulated upon siomycin A, a thiazole antibiotic, treatment, leading to inhibit tumor growth in vivo.</text>
</comment>
<comment type="domain">
<text evidence="13">The KA1 domain mediates binding to phospholipids and targeting to membranes.</text>
</comment>
<comment type="PTM">
<text evidence="35 36 37 38 40">Autophosphorylated: autophosphorylation of the T-loop at Thr-167 and Ser-171 is required for activation. Thr-478 phosphorylation during mitosis promotes interaction with PPP1R8 (Probable).</text>
</comment>
<comment type="disease">
<text>Defects in MELK are associated with some cancers, such as brain or breast cancers. Expression is dramatically increased in aggressive undifferentiated tumors, correlating with poor patient outcome in breast and brain cancers, suggesting a role in tumor-initiating cells and proliferation via its function in cell proliferation regulation.</text>
</comment>
<comment type="miscellaneous">
<text evidence="39 41">Potential therapeutic target for treatment of somatic tumors, such as brain and breast cancers, down-regulation of MELK inhibiting tumorigenesis (PubMed:17960622, PubMed:20861186).</text>
</comment>
<comment type="similarity">
<text evidence="34">Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. SNF1 subfamily.</text>
</comment>
<comment type="sequence caution" evidence="34">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA11492" version="2"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/MELKID43360ch9p13.html"/>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EC" id="2.7.10.2"/>
<dbReference type="EMBL" id="AB183427">
<property type="protein sequence ID" value="BAF73615.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB183428">
<property type="protein sequence ID" value="BAF73616.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D79997">
<property type="protein sequence ID" value="BAA11492.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK293284">
<property type="protein sequence ID" value="BAH11482.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK293447">
<property type="protein sequence ID" value="BAH11508.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK299164">
<property type="protein sequence ID" value="BAH12961.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK300761">
<property type="protein sequence ID" value="BAH13343.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK300821">
<property type="protein sequence ID" value="BAH13354.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK301131">
<property type="protein sequence ID" value="BAH13416.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK302374">
<property type="protein sequence ID" value="BAH13687.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL354932">
<property type="protein sequence ID" value="CAI11034.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL442063">
<property type="protein sequence ID" value="CAI11034.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL442063">
<property type="protein sequence ID" value="CAI16995.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL354932">
<property type="protein sequence ID" value="CAI16995.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471071">
<property type="protein sequence ID" value="EAW58303.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471071">
<property type="protein sequence ID" value="EAW58304.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014039">
<property type="protein sequence ID" value="AAH14039.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS59123.1">
<molecule id="Q14680-7"/>
</dbReference>
<dbReference type="CCDS" id="CCDS59124.1">
<molecule id="Q14680-8"/>
</dbReference>
<dbReference type="CCDS" id="CCDS59125.1">
<molecule id="Q14680-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS59126.1">
<molecule id="Q14680-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS59127.1">
<molecule id="Q14680-5"/>
</dbReference>
<dbReference type="CCDS" id="CCDS59128.1">
<molecule id="Q14680-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6606.1">
<molecule id="Q14680-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001243614.1">
<molecule id="Q14680-7"/>
<property type="nucleotide sequence ID" value="NM_001256685.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001243616.1">
<molecule id="Q14680-8"/>
<property type="nucleotide sequence ID" value="NM_001256687.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001243617.1">
<molecule id="Q14680-2"/>
<property type="nucleotide sequence ID" value="NM_001256688.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001243618.1">
<molecule id="Q14680-6"/>
<property type="nucleotide sequence ID" value="NM_001256689.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001243619.1">
<molecule id="Q14680-5"/>
<property type="nucleotide sequence ID" value="NM_001256690.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001243621.1">
<molecule id="Q14680-4"/>
<property type="nucleotide sequence ID" value="NM_001256692.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001243622.1">
<molecule id="Q14680-3"/>
<property type="nucleotide sequence ID" value="NM_001256693.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_055606.1">
<molecule id="Q14680-1"/>
<property type="nucleotide sequence ID" value="NM_014791.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011516378.1">
<molecule id="Q14680-1"/>
<property type="nucleotide sequence ID" value="XM_011518076.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011516379.1">
<molecule id="Q14680-1"/>
<property type="nucleotide sequence ID" value="XM_011518077.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011516380.1">
<molecule id="Q14680-1"/>
<property type="nucleotide sequence ID" value="XM_011518078.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011516381.1">
<molecule id="Q14680-1"/>
<property type="nucleotide sequence ID" value="XM_011518079.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011516383.1">
<molecule id="Q14680-6"/>
<property type="nucleotide sequence ID" value="XM_011518081.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011516384.1">
<molecule id="Q14680-6"/>
<property type="nucleotide sequence ID" value="XM_011518082.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011516385.1">
<molecule id="Q14680-6"/>
<property type="nucleotide sequence ID" value="XM_011518083.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011516386.1">
<molecule id="Q14680-6"/>
<property type="nucleotide sequence ID" value="XM_011518084.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.184339"/>
<dbReference type="PDB" id="4BKY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.83"/>
<property type="chains" value="A=2-340"/>
</dbReference>
<dbReference type="PDB" id="4BKZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=2-340"/>
</dbReference>
<dbReference type="PDB" id="4BL1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=2-340"/>
</dbReference>
<dbReference type="PDB" id="4D2P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A/B/C/D=1-336"/>
</dbReference>
<dbReference type="PDB" id="4D2T">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B/C/D=1-336"/>
</dbReference>
<dbReference type="PDB" id="4D2V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A/B/C/D=1-336"/>
</dbReference>
<dbReference type="PDB" id="4D2W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.92"/>
<property type="chains" value="A/B/C/D=1-336"/>
</dbReference>
<dbReference type="PDB" id="4IXP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A=1-340"/>
</dbReference>
<dbReference type="PDB" id="4UMP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D=1-336"/>
</dbReference>
<dbReference type="PDB" id="4UMQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=1-336"/>
</dbReference>
<dbReference type="PDB" id="4UMR">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=1-336"/>
</dbReference>
<dbReference type="PDB" id="4UMT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.98"/>
<property type="chains" value="A=1-336"/>
</dbReference>
<dbReference type="PDB" id="4UMU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.02"/>
<property type="chains" value="A=1-336"/>
</dbReference>
<dbReference type="PDB" id="5IH8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=3-330"/>
</dbReference>
<dbReference type="PDB" id="5IH9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A=3-330"/>
</dbReference>
<dbReference type="PDB" id="5IHA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="A=3-330"/>
</dbReference>
<dbReference type="PDB" id="5IHC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.14"/>
<property type="chains" value="A=3-330"/>
</dbReference>
<dbReference type="PDB" id="5K00">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.77"/>
<property type="chains" value="A=3-330"/>
</dbReference>
<dbReference type="PDBsum" id="4BKY"/>
<dbReference type="PDBsum" id="4BKZ"/>
<dbReference type="PDBsum" id="4BL1"/>
<dbReference type="PDBsum" id="4D2P"/>
<dbReference type="PDBsum" id="4D2T"/>
<dbReference type="PDBsum" id="4D2V"/>
<dbReference type="PDBsum" id="4D2W"/>
<dbReference type="PDBsum" id="4IXP"/>
<dbReference type="PDBsum" id="4UMP"/>
<dbReference type="PDBsum" id="4UMQ"/>
<dbReference type="PDBsum" id="4UMR"/>
<dbReference type="PDBsum" id="4UMT"/>
<dbReference type="PDBsum" id="4UMU"/>
<dbReference type="PDBsum" id="5IH8"/>
<dbReference type="PDBsum" id="5IH9"/>
<dbReference type="PDBsum" id="5IHA"/>
<dbReference type="PDBsum" id="5IHC"/>
<dbReference type="PDBsum" id="5K00"/>
<dbReference type="ProteinModelPortal" id="Q14680"/>
<dbReference type="SMR" id="Q14680"/>
<dbReference type="BioGrid" id="115171">
<property type="interactions" value="23"/>
</dbReference>
<dbReference type="IntAct" id="Q14680">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="MINT" id="MINT-7944803"/>
<dbReference type="STRING" id="9606.ENSP00000298048"/>
<dbReference type="BindingDB" id="Q14680"/>
<dbReference type="ChEMBL" id="CHEMBL4578"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2102"/>
<dbReference type="iPTMnet" id="Q14680"/>
<dbReference type="PhosphoSitePlus" id="Q14680"/>
<dbReference type="BioMuta" id="MELK"/>
<dbReference type="DMDM" id="50400857"/>
<dbReference type="EPD" id="Q14680"/>
<dbReference type="MaxQB" id="Q14680"/>
<dbReference type="PaxDb" id="Q14680"/>
<dbReference type="PeptideAtlas" id="Q14680"/>
<dbReference type="PRIDE" id="Q14680"/>
<dbReference type="DNASU" id="9833"/>
<dbReference type="Ensembl" id="ENST00000298048">
<molecule id="Q14680-1"/>
<property type="protein sequence ID" value="ENSP00000298048"/>
<property type="gene ID" value="ENSG00000165304"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000536329">
<molecule id="Q14680-5"/>
<property type="protein sequence ID" value="ENSP00000443550"/>
<property type="gene ID" value="ENSG00000165304"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000536860">
<molecule id="Q14680-8"/>
<property type="protein sequence ID" value="ENSP00000439792"/>
<property type="gene ID" value="ENSG00000165304"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000536987">
<molecule id="Q14680-4"/>
<property type="protein sequence ID" value="ENSP00000439184"/>
<property type="gene ID" value="ENSG00000165304"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000541717">
<molecule id="Q14680-7"/>
<property type="protein sequence ID" value="ENSP00000437804"/>
<property type="gene ID" value="ENSG00000165304"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000543751">
<molecule id="Q14680-6"/>
<property type="protein sequence ID" value="ENSP00000441596"/>
<property type="gene ID" value="ENSG00000165304"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000545008">
<molecule id="Q14680-2"/>
<property type="protein sequence ID" value="ENSP00000445452"/>
<property type="gene ID" value="ENSG00000165304"/>
</dbReference>
<dbReference type="GeneID" id="9833"/>
<dbReference type="KEGG" id="hsa:9833"/>
<dbReference type="UCSC" id="uc003zzn.5">
<molecule id="Q14680-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9833"/>
<dbReference type="DisGeNET" id="9833"/>
<dbReference type="GeneCards" id="MELK"/>
<dbReference type="HGNC" id="HGNC:16870">
<property type="gene designation" value="MELK"/>
</dbReference>
<dbReference type="HPA" id="HPA017214"/>
<dbReference type="MIM" id="607025">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14680"/>
<dbReference type="OpenTargets" id="ENSG00000165304"/>
<dbReference type="PharmGKB" id="PA134902874"/>
<dbReference type="eggNOG" id="KOG0583">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00870000136390"/>
<dbReference type="HOGENOM" id="HOG000233023"/>
<dbReference type="HOVERGEN" id="HBG106273"/>
<dbReference type="InParanoid" id="Q14680"/>
<dbReference type="KO" id="K08799"/>
<dbReference type="OMA" id="YELHETI"/>
<dbReference type="OrthoDB" id="EOG091G05V9"/>
<dbReference type="PhylomeDB" id="Q14680"/>
<dbReference type="TreeFam" id="TF314032"/>
<dbReference type="SignaLink" id="Q14680"/>
<dbReference type="SIGNOR" id="Q14680"/>
<dbReference type="ChiTaRS" id="MELK">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="MELK"/>
<dbReference type="GenomeRNAi" id="9833"/>
<dbReference type="PRO" id="PR:Q14680"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000165304"/>
<dbReference type="CleanEx" id="HS_MELK"/>
<dbReference type="ExpressionAtlas" id="Q14680">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q14680">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005938">
<property type="term" value="C:cell cortex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008289">
<property type="term" value="F:lipid binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030010">
<property type="term" value="P:establishment of cell polarity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0000086">
<property type="term" value="P:G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030097">
<property type="term" value="P:hemopoiesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008631">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to oxidative stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000226">
<property type="term" value="P:microtubule cytoskeleton organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0061351">
<property type="term" value="P:neural precursor cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd14078">
<property type="entry name" value="STKc_MELK"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR028375">
<property type="entry name" value="KA1/Ssp2_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001772">
<property type="entry name" value="KA1_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR033624">
<property type="entry name" value="MARK/par1"/>
</dbReference>
<dbReference type="InterPro" id="IPR034673">
<property type="entry name" value="MELK"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24346">
<property type="entry name" value="PTHR24346"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02149">
<property type="entry name" value="KA1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF103243">
<property type="entry name" value="SSF103243"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50032">
<property type="entry name" value="KA1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0446">Lipid-binding</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Maternal embryonic leucine zipper kinase" id="PRO_0000086323">
<location>
<begin position="1"/>
<end position="651"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="14">
<location>
<begin position="11"/>
<end position="263"/>
</location>
</feature>
<feature type="domain" description="KA1" evidence="15">
<location>
<begin position="602"/>
<end position="651"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="14">
<location>
<begin position="17"/>
<end position="25"/>
</location>
</feature>
<feature type="region of interest" description="UBA-like">
<location>
<begin position="282"/>
<end position="321"/>
</location>
</feature>
<feature type="region of interest" description="Autoinhibitory region">
<location>
<begin position="326"/>
<end position="651"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="14 16">
<location>
<position position="132"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="14">
<location>
<position position="40"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="23">
<location>
<position position="56"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="23">
<location>
<position position="163"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="20 23 24">
<location>
<position position="167"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="23">
<location>
<position position="171"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="23">
<location>
<position position="253"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="23">
<location>
<position position="336"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="23 24">
<location>
<position position="343"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="9 10 11 12 23 24">
<location>
<position position="356"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="24">
<location>
<position position="367"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="23">
<location>
<position position="391"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="23 24">
<location>
<position position="398"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="23">
<location>
<position position="407"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="24">
<location>
<position position="409"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="8 23 24">
<location>
<position position="431"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="19">
<location>
<position position="478"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="23 24">
<location>
<position position="494"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10 12">
<location>
<position position="498"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="7 8 9 10 12 23 24">
<location>
<position position="505"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="518"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10 12 23 24">
<location>
<position position="529"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="23 24">
<location>
<position position="529"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="23">
<location>
<position position="539"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_045208" evidence="32">
<location>
<begin position="1"/>
<end position="194"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_045209" evidence="32">
<original>MKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKP</original>
<variation>MVLE</variation>
<location>
<begin position="1"/>
<end position="135"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_045430" evidence="32 33">
<original>MKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLE</original>
<variation>MMNFSNIMNYMKLLGQ</variation>
<location>
<begin position="1"/>
<end position="87"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_045431" evidence="33">
<original>MKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLG</original>
<variation>MMNFSNIMNYMKLLGQ</variation>
<location>
<begin position="1"/>
<end position="48"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_044715" evidence="32">
<location>
<begin position="88"/>
<end position="158"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 8." id="VSP_046759" evidence="32">
<location>
<begin position="88"/>
<end position="135"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_046760" evidence="32">
<location>
<begin position="352"/>
<end position="392"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35233455." id="VAR_040794" evidence="26">
<original>T</original>
<variation>M</variation>
<location>
<position position="56"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35142210." id="VAR_040795" evidence="26">
<original>K</original>
<variation>R</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34655121." id="VAR_040796" evidence="26">
<original>R</original>
<variation>K</variation>
<location>
<position position="333"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55845414." id="VAR_040797" evidence="26">
<original>T</original>
<variation>I</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="sequence variant" description="In an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs144052967." id="VAR_040798" evidence="26">
<original>T</original>
<variation>M</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes dependence to reducing agents; when associated with V-70; A-89; A-154; A-168; A-169; A-204; A-286 and A-339." evidence="23">
<original>C</original>
<variation>V</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes dependence to reducing agents; when associated with V-29; A-89; A-154; A-168; A-169; A-204; A-286 and A-339." evidence="23">
<original>C</original>
<variation>V</variation>
<location>
<position position="70"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes dependence to reducing agents; when associated with V-29; V-70; A-154; A-168; A-169; A-204; A-286 and A-339." evidence="23">
<original>C</original>
<variation>A</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes enzymatic activity." evidence="19 23 25">
<original>D</original>
<variation>A</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-168; A-169; A-204; A-286 and A-339." evidence="23">
<original>C</original>
<variation>A</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autophosphorylation on tyrosine but still active on exogenous substrates." evidence="23">
<original>Y</original>
<variation>F</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes activation of serine/threonine-protein kinase activity and has only weak activity." evidence="20">
<original>T</original>
<variation>A</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phosphomimetic mutant that has similar kinase activity as wild-type." evidence="20">
<original>T</original>
<variation>D</variation>
<variation>E</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-169; A-204; A-286 and A-339." evidence="23">
<original>C</original>
<variation>A</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-168; A-204; A-286 and A-339." evidence="23">
<original>C</original>
<variation>A</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes activation of serine/threonine-protein kinase activity and has only weak activity." evidence="23">
<original>S</original>
<variation>A</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inactive." evidence="23">
<original>S</original>
<variation>D</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-168; A-169; A-286 and A-339." evidence="23">
<original>C</original>
<variation>A</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inactive." evidence="23">
<original>DDD</original>
<variation>KKK</variation>
<location>
<begin position="283"/>
<end position="285"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-168; A-169; A-204; and A-339." evidence="23">
<original>C</original>
<variation>A</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes dependence to reducing agents; when associated with V-29; V-70; A-89; A-154; A-168; A-169; A-204 and A-286." evidence="23">
<original>C</original>
<variation>A</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="19">
<original>T</original>
<variation>A</variation>
<location>
<position position="345"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="19">
<original>T</original>
<variation>A</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="19">
<original>T</original>
<variation>A</variation>
<location>
<position position="409"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="19">
<original>T</original>
<variation>A</variation>
<location>
<position position="415"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="19">
<original>T</original>
<variation>A</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with PPP1R8." evidence="19">
<original>T</original>
<variation>A</variation>
<location>
<position position="446"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with PPP1R8." evidence="19">
<original>T</original>
<variation>A</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with PPP1R8." evidence="19">
<original>T</original>
<variation>A</variation>
<location>
<position position="466"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly inhibits interaction with PPP1R8. Enhances enzymatic activity." evidence="19">
<original>T</original>
<variation>A</variation>
<location>
<position position="478"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="19">
<original>T</original>
<variation>A</variation>
<location>
<position position="518"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAH12961." ref="3" evidence="34">
<original>I</original>
<variation>M</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAH12961." ref="3" evidence="34">
<original>T</original>
<variation>A</variation>
<location>
<position position="398"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAH11482." ref="3" evidence="34">
<original>T</original>
<variation>A</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAH13343." ref="3" evidence="34">
<original>C</original>
<variation>R</variation>
<location>
<position position="474"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAH13354." ref="3" evidence="34">
<original>P</original>
<variation>L</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="4"/>
<end position="6"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="7"/>
<end position="9"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="11"/>
<end position="19"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="20"/>
<end position="22"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="24"/>
<end position="30"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="31"/>
<end position="33"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="36"/>
<end position="43"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="44"/>
<end position="47"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="48"/>
<end position="50"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="51"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="72"/>
<end position="77"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="79"/>
<end position="87"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="94"/>
<end position="101"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="106"/>
<end position="125"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="135"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="138"/>
<end position="140"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="146"/>
<end position="148"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="157"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="163"/>
<end position="166"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="172"/>
<end position="174"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="177"/>
<end position="181"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="187"/>
<end position="204"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="214"/>
<end position="223"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="234"/>
<end position="243"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="248"/>
<end position="250"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="254"/>
<end position="258"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="261"/>
<end position="264"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="265"/>
<end position="267"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="279"/>
<end position="281"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="284"/>
<end position="291"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="294"/>
<end position="296"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="298"/>
<end position="306"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="312"/>
<end position="326"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4BKY"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4BKZ"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4D2T"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4IXP"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4UMP"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5K00"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250"/>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00565"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11802789"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12400006"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14699119"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14976552"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15908796"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16159311"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16216881"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16628004"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17280616"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20420823"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21145462"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21558073"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21806965"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8724849"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source ref="1"/>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<evidence key="35" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="14699119"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="14976552"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="16216881"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="16628004"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="17960622"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20420823"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20861186"/>
</source>
</evidence>
<sequence length="651" mass="74642" checksum="57F05CDC6122E570" modified="2004-07-19" version="3">
MKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEA
LKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAV
AYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELI
QGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLL
QQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQT
MEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSSFSCGQASATPFTDIKSNNWSLEDV
TASDKNYVAGLIDYDWCEDDLSTGAATPRTSQFTKYWTESNGVESKSLTPALCRTPANKL
KNKENVYTPKSAVKNEEYFMFPEPKTPVNKNQHKREILTTPNRYTTPSKARNQCLKETPI
KIPVNSTGTDKLMTGVISPERRCRSVELDLNQAHMEETPKRKGAKVFGSLERGLDKVITV
LTRSKRKGSARDGPRRLKLHYNVTTTRLVNPDQLLNEIMSILPKKHVDFVQKGYTLKCQT
QSDFGKVTMQFELEVCQLQKPDVVGIRRQRLKGDAWVYKRLVEDILSSCKV
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>